Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants.
about
Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesModulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutantsNeisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHBToll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis.Vaccine development against Neisseria meningitidis.A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity.Preclinical evaluation of MenB vaccines: prerequisites for clinical development.Neisseria meningitidis B vaccines: recent advances and possible immunization policies.Outer membrane vesicles: an attractive candidate for pertussis vaccines.Absence of immune responses with xenogeneic collagen and elastin.The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.Moderate levels of glyphosate and its formulations vary in their cytotoxicity and genotoxicity in a whole blood model and in human cell lines with different estrogen receptor status
P2860
Q26783884-CD1283E4-ADB4-4C8B-B247-0CCEE7EEED58Q34138990-00CAAC54-E967-45A5-A087-D6FEAC9CF60BQ34580302-E50FD530-A431-4454-BB21-14CDC7F17478Q34783257-7548E6E6-A70E-452B-A7B1-21CF74F010EBQ35043042-656CFEF7-124A-4E2D-94E9-C1C13DAFEA99Q35924773-A0496616-5FB6-468D-ABA7-D74A33D224C0Q36764359-46EB1E10-D353-4F77-8DE0-BE4FC190A7E3Q37274707-6160BAF3-95D8-47FE-9289-FDA145699981Q37483629-40914EBD-66AF-401D-AA65-E7878D9517C0Q38068953-76E5409B-FF47-443B-B751-E201D5FB99A9Q38183156-72B3696D-B0D0-41FA-8B2A-52BAA7FB6ABAQ40410058-BEF077D8-8D4F-4886-8B80-29CA45AD59DEQ41097226-9D6CBDE8-A20E-4EB4-B481-264F865326F8Q42131377-DC2F2111-59A6-49D3-B176-C4D8C45400DDQ57298337-9361785A-099F-4531-A50A-5151FC21C2AD
P2860
Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Evaluation of a whole-blood cy ...... rom lipid A acylation mutants.
@en
Evaluation of a whole-blood cy ...... rom lipid A acylation mutants.
@nl
type
label
Evaluation of a whole-blood cy ...... rom lipid A acylation mutants.
@en
Evaluation of a whole-blood cy ...... rom lipid A acylation mutants.
@nl
prefLabel
Evaluation of a whole-blood cy ...... rom lipid A acylation mutants.
@en
Evaluation of a whole-blood cy ...... rom lipid A acylation mutants.
@nl
P2093
P2860
P356
P1476
Evaluation of a whole-blood cy ...... rom lipid A acylation mutants.
@en
P2093
Mark B Stoddard
Paul B Keiser
Valerian Pinto
Wendell Zollinger
P2860
P304
P356
10.1128/CVI.00342-09
P577
2009-11-18T00:00:00Z